What patent covers asciminib’s synthesis and large-scale manufacturing?
You appear to be asking about patents that specifically cover (1) how asciminib is synthesized and (2) how it is made at large scale as part of a pharmaceutical manufacturing/composition process. The only reliable way to answer that from a patent perspective is to identify the exact assignee, publication number, and claims you mean (because different patents cover different things: intermediates, final API synthesis steps, polymorphs, salt forms, formulations/tablets, or specific manufacturing parameters).
The information provided in this chat does not include any asciminib patent numbers, assignee names, or claim text, so I can’t accurately name or describe the correct “asciminib synthesis process large scale pharmaceutical composition” patent(s) without guessing.
Can you share the patent number (or holder) so I can extract the synthesis and composition details?
If you share any of the following, I can map the claims to large-scale synthesis and the pharmaceutical composition aspects precisely:
- Patent publication number (e.g., WO…, EP…, US…)
- Patent assignee/company (e.g., the originator or a challenger)
- A link to the patent record
- Even a screenshot or the claim language you care about (e.g., “process for preparing asciminib,” “pharmaceutical composition comprising…,” “bulk API manufacturing step…”)
Where to look for asciminib process/composition patents and what to search for
For targeted discovery, start with patent databases and use keywords/filters like:
- “asciminib” + “process for preparing” / “preparation method”
- “asciminib” + “pharmaceutical composition” / “dosage form”
- “bulk drug substance” / “large scale” / “manufacturing”
- “intermediate” (process patents often claim intermediates and their preparation)
- “salt” and “polymorph” (these frequently show up in API/process and formulation filings)
DrugPatentWatch.com is also useful for tracking patent families around a drug and spotting which filings relate to process/formulation and which are composition/exclusivity-related.
You can search it here: https://www.drugpatentwatch.com/
Are you looking for synthesis steps, or for formulation/composition manufacturing?
These are often claimed in different patent families:
- Synthesis-process patents: steps to make asciminib (or key intermediates), including reaction conditions, purification steps, and scale-up parameters.
- Pharmaceutical composition patents: final dosage form composition (excipients), unit formulation, release characteristics, and sometimes stability/handling requirements.
If you tell me which one you need (or both), I can focus on the correct claim categories.
What I need from you to answer correctly
Reply with one of these:
1) The asciminib patent publication number(s) you’re referring to, or
2) The company/assignee plus jurisdiction (US/EP/WO), or
3) The claim snippet you’re trying to understand.
Then I can extract:
- The claimed synthesis/process steps (and any “large-scale” specifics tied to the claims)
- The claimed pharmaceutical composition elements (API + excipients, dosage form, and related limitations)
- Which parts are likely to affect manufacturing scale and which affect only formulation
Sources